Aptose Biosciences Inc (APTO): If one or both drugs work, what size mar...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	77
Boards Moderated	0
Alias Born	08/07/2006

spiderman3600

Re: None

Wednesday, 08/23/2023 12:51:43 PM

Wednesday, August 23, 2023 12:51:43 PM

If one or both drugs work, what size market are they looking at and what time frame? tia

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent APTO News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:20:21 PM
Aptose Announces Results from Special Meeting of Shareholders • GlobeNewswire Inc. • 09/05/2024 08:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:35:07 PM
Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop Tuspetinib • GlobeNewswire Inc. • 08/30/2024 08:30:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 08:35:12 PM
Aptose Announces Adjournment of its Special Meeting of Shareholders • GlobeNewswire Inc. • 08/15/2024 08:30:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 09:22:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 09:15:13 PM
Aptose Reports Results for the Second Quarter 2024 • GlobeNewswire Inc. • 08/08/2024 09:06:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:30:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 09:00:14 PM
Aptose Announces Receipt of Deficiency Notice from Nasdaq • GlobeNewswire Inc. • 07/19/2024 09:00:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/17/2024 03:43:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:40:15 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:35:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 02:32:05 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/03/2024 10:05:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 12:05:15 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/15/2024 03:47:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 09:06:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:15:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 03:35:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:45:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:00:16 PM

More APTO News

InvestorsHub NewsWire

FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover